Status:
NOT_YET_RECRUITING
Comparison of Continuous Intravenous Lidocaine Infusion Versus ESP Block for Rib Fracture Analgesia
Lead Sponsor:
Stanford University
Conditions:
Rib Fractures
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Recently in 2016, a new interfascial plane nerve block was developed for thoracic analgesia known as the erector spinae plane block (ESPB). Since its development for thoracic neuropathic pain, the ESP...
Eligibility Criteria
Inclusion
- \- All adult patients admitted to Stanford Health Care with two or more acute traumatic rib fractures.
Exclusion
- Hemodynamically instability,
- Mechanical ventilation,
- Polytrauma (defined as bone or organ injury outside the thorax),
- Pregnancy,
- Incarceration
- Local anesthetic allergy or contraindications to lidocaine (Stokes-Adams syndrome, Wolff-Parkinson-White syndrome, or severe degrees of sinoatrial, atrioventricular, or intraventricular block)
- Chronic opioid use.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04707183
Start Date
May 1 2025
End Date
May 1 2026
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Health Care
Stanford, California, United States, 94305